A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001

The Cancer and Leukemia Group B (CALGB), now part of the Alliance for Clinical Trials in Oncology, conducted a multicenter, single-arm, phase 2 study in patients ≥60 years with FMS-like tyrosine kinase 3 (FLT3)–mutated acute myeloid leukemia (AML). In this study, sorafenib was added to daunorubicin...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Blood Adv
Main Authors: Uy, Geoffrey L., Mandrekar, Sumithra J., Laumann, Kristina, Marcucci, Guido, Zhao, Weiqiang, Levis, Mark J., Klepin, Heidi D., Baer, Maria R., Powell, Bayard L., Westervelt, Peter, DeAngelo, Daniel J., Stock, Wendy, Sanford, Ben, Blum, William G., Bloomfield, Clara D., Stone, Richard M., Larson, Richard A.
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Hematology 2017
Ábhair:
Myeloid Neoplasia
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5637402/
https://ncbi.nlm.nih.gov/pubmed/29034366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016003053
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla